Lastly, while our ELISA could distinguish between malignant and non-malignant samples with a relatively high degree of confidence, the assessment of serum STn using our ELISA did not outperform or augment CA-125 in the detection of serous ovarian cancer. This evidence concerns the gene MUC16 and ovarian serous adenocarcinoma.